A Shot in the Arm for Flu Research: Integral Molecular Introduces Off-the-Shelf Reagents to Evaluate 2023/2024 Influenza Vaccine Efficacy

/PRNewswire/ -- Integral Molecular, a leader in providing safe, off-the-shelf Reporter Virus Particles (RVPs) to study vaccine efficacy, has expanded its...

Related Keywords

Philadelphia ,Pennsylvania ,United States ,Kyle Doolan ,Molecular Inc ,Research At Integral Molecular ,Twitter ,Reporter Virus Particles ,Integral Molecular ,Public Relations ,